EUVIMEDEUVIMED entdecken
Übersichtsarbeit

From mitochondrial dysfunction to neuroinflammation in Parkinson’s disease: Pathogenesis and mitochondrial therapeutic approaches

Negar Ebadpour, Mahmoud Mahmoudi, Ramiar Kamal Kheder, Mohammad Abavisani, Zahra Baridjavadi, Narges Abdollahi, Seyed-Alireza Esmaeili

International Immunopharmacology · 2024-12 · 142 · 113015

DOI: 10.1016/j.intimp.2024.113015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024-12. Verfasst von Negar Ebadpour und 6 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Immunology Department, Faculty of Medicine, Mashhad University of …. Hauptthemen laut MEDLINE: Parkinson Disease, Mitochondria, Neuroinflammatory Diseases. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a prevalent and intricate neurological condition resulting from a combination of several factors, such as genetics, environment, and the natural process of aging. Degeneration of neurons in the substantia nigra pars compacta (SN) can cause motor and non-motor impairments in patients with PD. In PD's etiology, inflammation and mitochondrial dysfunction play significant roles in the disease's development. Studies of individuals with PD have revealed increased inflammation in various brain areas. Furthermore, mitochondrial dysfunction is an essential part of PD pathophysiology. Defects in the components of the mitochondrial nucleus, its membrane or internal signaling pathways, mitochondrial homeostasis, and morphological alterations in peripheral cells have been extensively documented in PD patients. According to these studies, neuroinflammation and mitochondrial dysfunction are closely connected as pathogenic conditions in neurodegenerative diseases like PD. Given the mitochondria's role in cellular homeostasis maintenance in response to membrane structural flaws or mutations in mitochondrial DNA, their dynamic nature may present therapeutic prospects in this area. Recent research investigates mitochondrial transplantation as a potential treatment for Parkinson's disease in damaged neurons. This review delves into the impact of inflammation and mitochondrial dysfunction on PD occurrence, treatment approaches, and the latest developments in mitochondrial transplantation, highlighting the potential consequences of these discoveries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMitochondriaNeuroinflammatory DiseasesHumansAnimalsDNA, MitochondrialInflammation

Stichwörter der Autor:innen

MitochondriaMitotherapyNeurodegenerative diseaseNeuroinflammationParkinson’s disease

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Immunology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Mashhad U…
  • Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Immunology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Medical Laboratory Science Department, College of Science, University of Raparin, Rania, Sulaymaniyah, Iraq; Department of Medical Analysis, Faculty of Applied Science, Tishk International University, Erbil, Iraq.
  • Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Immunology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Esmaeiliar@mums.a…

Förderung

  • Mashhad University of Medical Sciences

Zitieren

APA

Ebadpour, N., Mahmoudi, M., Kamal Kheder, R., Abavisani, M., Baridjavadi, Z., Abdollahi, N., & Esmaeili, S. A. (2024). From mitochondrial dysfunction to neuroinflammation in Parkinson’s disease: Pathogenesis and mitochondrial therapeutic approaches. International Immunopharmacology, 142, 113015. https://doi.org/10.1016/j.intimp.2024.113015

Vancouver

Ebadpour N, Mahmoudi M, Kamal Kheder R, Abavisani M, Baridjavadi Z, Abdollahi N, et al. From mitochondrial dysfunction to neuroinflammation in Parkinson’s disease: Pathogenesis and mitochondrial therapeutic approaches. International Immunopharmacology. 2024;142:113015. doi:10.1016/j.intimp.2024.113015

BibTeX
@article{Ebadpour2024,
  author = {Ebadpour, Negar and Mahmoudi, Mahmoud and Kamal Kheder, Ramiar and Abavisani, Mohammad and Baridjavadi, Zahra and Abdollahi, Narges and Esmaeili, Seyed-Alireza},
  title = {From mitochondrial dysfunction to neuroinflammation in Parkinson’s disease: Pathogenesis and mitochondrial therapeutic approaches},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {142},
  pages = {113015},
  doi = {10.1016/j.intimp.2024.113015}
}
Kostenlos starten →